Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Candel Therapeutics (CADL) Debt Ratio (2020 - 2025)

Candel Therapeutics' Debt Ratio history spans 4 years, with the latest figure at 0.5 for Q4 2023.

  • On a quarterly basis, Debt Ratio rose 91.58% to 0.5 in Q4 2023 year-over-year; TTM through Dec 2023 was 0.5, a 91.58% increase, with the full-year FY2023 number at 0.5, up 91.58% from a year prior.
  • Debt Ratio hit 0.5 in Q4 2023 for Candel Therapeutics, up from 0.41 in the prior quarter.
  • Over the last five years, Debt Ratio for CADL hit a ceiling of 0.5 in Q4 2023 and a floor of 0.01 in Q1 2022.
  • Historically, Debt Ratio has averaged 0.21 across 4 years, with a median of 0.25 in 2022.
  • Biggest five-year swings in Debt Ratio: crashed 48.09% in 2021 and later soared 5255.79% in 2023.
  • Tracing CADL's Debt Ratio over 4 years: stood at 0.01 in 2020, then crashed by 48.09% to 0.01 in 2021, then skyrocketed by 4042.14% to 0.26 in 2022, then soared by 91.58% to 0.5 in 2023.
  • Business Quant data shows Debt Ratio for CADL at 0.5 in Q4 2023, 0.41 in Q3 2023, and 0.35 in Q2 2023.